Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 934 000 KRW 0.21% Market Closed
Market Cap: 66.5T KRW
Have any thoughts about
Samsung Biologics Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

49.7
Current
54.6
Median
23.2
Industry
Lower than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
49.7
=
Enterprise Value
65.8T KRW
/
EBIT
1.3T KRW
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
47.8
2-Years Forward
EV/EBIT
40.7
3-Years Forward
EV/EBIT
34.4

See Also

Discover More